G01N 2333/61
Growth hormones [gh]
Official title: Growth hormones [GH] (Somatotropin)
G01N2333/61 (Growth hormones [gh]) appears on 59 US grants and 33 published applications in this corpus.
Search patents in G01N- Granted patents
- 59
- Published applications
- 33
- Assignees
- 43
- Inventors
- 113
- Latest grant
- 3 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 1 | 0 |
| 1990 | 4 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 6 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 3 | 0 |
| 2002 | 3 | 0 |
| 2003 | 2 | 1 |
| 2004 | 3 | 0 |
| 2005 | 1 | 3 |
| 2006 | 0 | 2 |
| 2007 | 1 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 2 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 2 |
| 2017 | 2 | 2 |
| 2018 | 2 | 1 |
| 2019 | 1 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 3 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Detecting and treating growth hormone deficiency3 Feb 2026US 12,539,293 B2Lumos Pharma, Inc.
- Method for treating growth hormone deficiency employing hGH fusion protein30 Sep 2025US 12,427,186 B2Genexine, Inc.
- Use of macimorelin in assessing growth hormone deficiency in children9 May 2023US 11,644,474 B2Æterna Zentaris GmbH
- Detecting and treating growth hormone deficiency1 Feb 2022US 11,234,969 B2Lumos Pharma, Inc.
- Detecting and treating growth hormone deficiency26 Jan 2021US 10,898,472 B2Lumos Pharma, Inc.
- Detecting and treating growth hormone deficiency3 Jul 2025US 2025/0213536 A1Lumos Pharma, Inc.
- Method for Identifying Human Growth Hormone Proteoform (hGHP) Pattern Biomarker15 Sep 2022US 2022/0291230 A1Shandong First Medical University & Shandong Academy of Medical Sciences
- Detecting and treating growth hormone deficiency12 May 2022US 2022/0142989 A1Lumos Pharma, Inc.
- Use of macimorelin in assessing growth hormone deficiency in children27 Jan 2022US 2022/0026449 A1Ætema Zentaris GmbH
- Detecting and treating growth hormone deficiency14 Oct 2021US 2021/0315867 A1Lumos Pharma, Inc.
Most cited
By later US patents
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998
- Monovalent phage display562US 5,821,047 AGenentech, Inc. · 1998
- Human growth hormone variants having greater affinity for human growth hormone receptor at site 1133US 5,534,617 AGenentech, Inc. · 1996
- Method for identifying active domains and amino acid residues in polypeptides and hormone variants119US 5,580,723 AGenetech, Inc. · 1996
- Growth hormone variants with altered binding properties102US 5,688,666 AGenentech, Inc. · 1997